# Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation

> **NCT02194881** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 57 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** CF patients with a G551D mutation and treated with Ivacaftor

## Key facts

- **NCT ID:** NCT02194881
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-02
- **Final completion:** 2016-05
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02194881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02194881, "Ivacaftor in French Patients With Cystic Fibrosis and a G551D Mutation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02194881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*